NAXITAMAB Pharmacologic Class Indexing
- Class set ID
- aa2fb343-e0db-4a9a-8584-da3f12130dca
- Version
- 1
- Effective date
- 20210614
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use DANYELZA safely and effectively. See full prescribing information for DANYELZA. DANYELZA ® (naxitamab-gqgk) injection, for intravenous use Initial U.S. Approval: 2020 | BTG International Inc. | 20260526 | 2 |
| These highlights do not include all the information needed to use DANYELZA safely and effectively. See full prescribing information for DANYELZA. DANYELZA ® (naxitamab-gqgk) injection, for intravenous use Initial U.S. Approval: 2020 | Y-mAbs Therapeutics, Inc. | 20250903 | 9 |